相似文献
1
Management of Psychiatric Disease in Hepatitis C Treatment Candidates.
Curr Hepat Rep. 2010 Apr 6;9(2):113-118. doi: 10.1007/s11901-010-0035-5.
2
Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement.
J Hepatol. 2012 Dec;57(6):1379-90. doi: 10.1016/j.jhep.2012.07.037. Epub 2012 Aug 7.
3
Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFN alpha-induced depression.
Gastroenterol Clin North Am. 2004 Mar;33(1 Suppl):S35-50. doi: 10.1016/j.gtc.2003.12.005.
4
[Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
Encephale. 2005 May-Jun;31(3):349-57. doi: 10.1016/s0013-7006(05)82400-5.
5
Prevalence and detection of neuropsychiatric adverse effects during hepatitis C treatment.
Int J Clin Pharm. 2015 Dec;37(6):1143-51. doi: 10.1007/s11096-015-0177-1. Epub 2015 Aug 13.
6
[Benefits of a preventive psychiatric accompaniment in patients Hepatitis C Virus seropositive (HCV): prospective study concerning 39 patients].
Encephale. 2003 Jul-Aug;29(4 Pt 1):362-5.
7
Pegylated interferon-alpha2b plus ribavirin therapy in patients with hepatitis C and psychiatric disorders: results of a cohort study.
Antivir Ther. 2010;15(4):599-606. doi: 10.3851/IMP1566.
8
Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C.
Aliment Pharmacol Ther. 2009 Nov 15;30(10):1049-59. doi: 10.1111/j.1365-2036.2009.04123.x. Epub 2009 Aug 18.
9
Aminoadamantanes versus other antiviral drugs for chronic hepatitis C.
Cochrane Database Syst Rev. 2014 Jun 17;2014(6):CD011132. doi: 10.1002/14651858.CD011132.pub2.
10
Psychiatric comorbidity does not predict interferon treatment completion rates in hepatitis C seropositive veterans.
J Clin Gastroenterol. 2007 Mar;41(3):322-8. doi: 10.1097/01.mcg.0000225629.22286.96.
引用本文的文献
1
Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders.
World J Gastroenterol. 2023 Jul 7;29(25):4085-4098. doi: 10.3748/wjg.v29.i25.4085.
2
Double blind, randomised trial to compare efficacy of escitalopram versus citalopram for interferon induced depression in hepatitis C patients.
Contemp Clin Trials Commun. 2020 Jul 19;19:100622. doi: 10.1016/j.conctc.2020.100622. eCollection 2020 Sep.
3
The Patient-Provider Relationship Is Associated with Hepatitis C Treatment Eligibility: A Prospective Mixed-Methods Cohort Study.
PLoS One. 2016 Feb 22;11(2):e0148596. doi: 10.1371/journal.pone.0148596. eCollection 2016.
4
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.
Neuroscience. 2013 Aug 29;246:199-229. doi: 10.1016/j.neuroscience.2013.04.060. Epub 2013 May 3.
5
Hepatitis C: management of side effects in the era of direct-acting antivirals.
Curr Gastroenterol Rep. 2013 Jan;15(1):305. doi: 10.1007/s11894-012-0305-1.
本文引用的文献
1
Poor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatment.
Psychiatry Res. 2010 May 15;177(1-2):240-5. doi: 10.1016/j.psychres.2009.02.011. Epub 2010 Apr 9.
2
Major depression during interferon-alpha treatment: vulnerability and prevention.
Dialogues Clin Neurosci. 2009;11(4):417-25. doi: 10.31887/DCNS.2009.11.4/felotrich.
3
Managing depression during hepatitis C treatment.
Can J Psychiatry. 2009 Sep;54(9):614-25. doi: 10.1177/070674370905400906.
4
Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality.
Brain Behav Immun. 2009 Nov;23(8):1109-16. doi: 10.1016/j.bbi.2009.07.001. Epub 2009 Jul 15.
5
Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism.
Biol Psychiatry. 2009 Feb 15;65(4):344-8. doi: 10.1016/j.biopsych.2008.08.009. Epub 2008 Sep 18.
6
Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression.
Biol Psychiatry. 2009 Feb 15;65(4):296-303. doi: 10.1016/j.biopsych.2008.08.010. Epub 2008 Sep 18.
7
Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment.
Mol Psychiatry. 2009 Dec;14(12):1095-104. doi: 10.1038/mp.2008.48. Epub 2008 May 6.
8
High frequency of unrecognized mental disorders in HCV-infected patients.
Gen Hosp Psychiatry. 2008 Jan-Feb;30(1):80-2. doi: 10.1016/j.genhosppsych.2007.08.014.
9
Impaired anger control as an underappreciated side effect of treatments for chronic HCV infection in HIV-HCV coinfected patients.
J Clin Gastroenterol. 2008 Jan;42(1):92-6. doi: 10.1097/01.mcg.0000225645.75651.b8.
10
Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study.
Gut. 2008 Apr;57(4):531-6. doi: 10.1136/gut.2007.131607. Epub 2007 Dec 13.
Zotero 插件